Conceivable Life Sciences
New York
About Conceivable Life Sciences
Conceivable Life Sciences develops automated in vitro fertilization (IVF) laboratory systems using AI, robotics, and machine vision. Its AURA platform performs the sequence of IVF procedures such as dish preparation, sperm and egg handling, injection (ICSI), incubation, vitrification, and thawing through coordinated, software-defined workstations. The system records traceability for each specimen and has shown clinical outcomes comparable to established IVF clinics in early trials, including an IRB-approved pilot with successful pregnancies. The company is advancing commercial deployments and preparing for broader rollout.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $85.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: conceivable-lifesciences.com
- Phone: 917-657-2175
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/conceivable-life-sciences-23907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.